Several studies have reported that integrins such as αvβ3 promote resistance to chemotherapy, molecularly targeted therapy and radiotherapy in several cancers including ovarian cancer by overcoming anoikis, autophagy, and apoptosis by increasing p27 and Bcl-2 levels and inhibition of caspase function48–51. This evidence concerns the gene BCL2 and ovarian cancer.